|Position||Trades||Duration||Win rate||Win/loss||Avg win||Avg loss||Return|
|Position||Trades||Duration||Win Rate||Win/Loss||Avg Win||Avg Loss||Return|
Resapp Health (RAP.AX)
DETREND PRICE OSCILLATOR
Trading: SELL @ $0.155
Signal Strength: STRONG
Indicator can be used in isolation or in additional to another technical indicator to confirmation for trading entry. This indicator has the ability to highlight trends across numerous timeframes. This indicator has the ability to smooth historical results to illustrate trend initiation and status. Although this is a simple trend following indicator & can provide good results when coupled with the right indicator. Note, this indicator does not work well in ranging markets producing unwanted whipsaws and false signals.
Resapp Health (ASX:RAP) currently has a confirmed downtrend. Price is currently below the displaced moving average for RAP Currently, the return on DPO20 is 0.0%.
The Detrended Price Oscillator (DPO) is an indicator designed to remove trend from price and make it easier to identify cycles. DPO does not extend to the last date because it is based on a displaced moving average. However alignment with the most recent is not an issue because DPO is not a momentum oscillator. Instead DPO is used to identify cycle’s highs/lows and estimate cycle length.
Calculation: Detrended Price Oscillator (DPO):
1) Price (X/2 + 1) periods ago minus X-period simple moving average.
Where X is the number of periods;
PROFILE: Resapp Health (RAP.AX)
Stock Exchange: ASX
Company: Resapp Health
Ticker Codes: | RAP.AX | ASX:RAP |
ResApp Health Limited develops and commercializes the ResApp technology to provide health care solutions for respiratory disease. The company offers telehealth companies with point of care diagnostic solutions to integrate into their platforms. It provides SMARTCOUGH-C, a multi-site, double blind, and prospective clinical study to investigate ResAppDx for the diagnosis of respiratory disease in infants and children using cough sounds, as well as the diagnosis of pneumonia, croup, bronchiolitis, asthma/reactive airways disease, lower respiratory tract disease, and upper respiratory tract infection. The company was formerly known as Narhex Life Sciences Limited. ResApp Health Limited was founded in 2014 and is headquartered in Brisbane, Australia.
|MOY Millennium Minerals||0.13||13.6||1,861,319||-0.05||BEARISH|
|ONE Oneview Healthcare||0.29||11.8||184,305||-0.02||BEARISH|
|SLR Silver Lake Resources||1.45||8.2||9,252,383||-0.07||BEARISH|
|MXI Maxitra Industries||0.33||8.2||24,282||-0.07||BEARISH|
|AEF Australian Ethical Investments||2.03||6.8||76,257||-0.35||BEARISH|
|WAF West African Resources||0.39||5.4||3,897,020||-2.27||BEARISH|
|AJM Altura Mining||0.11||4.8||879,399||-0.03||BEARISH|
|MVP Medical Developments||6.06||4.7||189,975||-0.57||BEARISH|
|EDE Eden Energy||0.07||4.6||4,448,760||-0.01||BEARISH|